From: Magnesium treatment for neuroprotection in ischemic diseases of the brain
Author | Study setup | Treatment arms and comedication | Individuals | Results |
---|---|---|---|---|
A | Â | Â | Â | Â |
Schendel et al., 1996 [61] | Observational | Preterm administration for tocolysis. Dose variable, observational study | 1097 births with very low birth-weight | Reduced risk for cerebral palsy and mental retardation |
Crowther et al., 2003 [64] | Randomized | Preterm administration of 16 mmol MgSO4 followed by 4 mmol/h for 24 hours to mother vs. placebo | 1062 women in gest. week 30 or less with birth planned within 24 hours | Lower rate of pediatric mortality and cerebral palsy in the treatment group |
Marret et al., 2007 [63] | Randomized | Preterm administration of 16 mmol MgSO4 (4 g) single-dose over 30 minutes | 573 women in gest. week 33 or less with birth planned within 24 hours | Non-significant reduction of infant mortality and white matter injury |
Magpie Trial Follow-Up Collaborative Group, 2007 [66] | Randomized | Preterm administration of 16 mmol MgSO4 followed by 4 mmol/h for 24 hours to mother vs. placebo | 3283 children born before gest. week 37 | Non-significant reduction of disability after 18 months |
Rouse et al., 2008 [65] | Randomized | Preterm administration of 24 mmol MgSO4, followed by 8 mmol/h | 2241 women in gest. week 24 – 32 with birth anticipated within 24 hours | Significant reduction of cerebral palsy |
B | Â | Â | Â | Â |
Levene et al., 1995 [68] | open | MgSO4 400 mg/kg vs. 250 mg/kg | 15 full-term neonates with asphyxia | 400 mg/kg: Serum level 3,6 mmol/l, profound hypotension and respiratory depression |
250 mg/kg: Serum level 2.42 mmol/kg, no effect on herat rate, blood pressure and respiration | ||||
Groenendaal et al., 2002 [69] | Randomized | MgSO4 (250 mg/kg 30 min after birth and 125 mg/kg after 24 and 48 hours vs. placebo | 22 full-term neonates with asphyxia | No effect on pathological EEG patterns |
Ichiba et al., 2002 [70] | Randomized | MgSO4 (3 × 250 mg/kg in 24-hour intervals) vs. placebo | 34 full-term neonates with asphyxia | Less pathological CT- and abnormal EEG-findings. Higher rate of oral feeding and good short-term outcome ( at 14 days of age) in magnesium-treated children |
Gathwala et al., 2006 [71] | Randomized | MgSO4 (250 mg/kg 30 min after birth and 125 mg/kg after 24 and 48 hours vs. placebo | 40 full-term neonates with asphyxia | Safe use of magnesium. No change in heart-rate, respiratory rate of blood pressure |
Bhat et al., 2009 [72] | Randomized | MgSO4 (3 × 250 mg/kg in 24-hour intervals) vs. placebo | 40 full-term neonates with asphyxia | Less neurological abnormalities and pathological CT findings |
Gethwala et al., 2010 [73] | Randomized | MgSO4 (250 mg/kg 30 min after birth and 125 mg/kg after 24 and 48 hours vs. placebo | 40 full-term neonates with asphyxia | Less EEG- and CT abnormalities and better short-term outcome in magnesium-treated children |